MIF and type 2 diabetes mellitus: Circulating plasma MIF and mononuclear cell MIF mRNA expression are associated with increasing BMI and fatty acid concentration, impaired glucose tolerance and T2D [23]–[25], whereas reducing body weight or metformin treatment decreases serum MIF levels [26], [27].